1. HBW Insight
  2. >>Archive

In Brief: CMA Bill Picks Up Democrat Backer; Avon Slashing Headcount; More

While still short of the House support ICMAD initially anticipated for the Cosmetic Modernization Amendments of 2015, the proposed bill now has a second cosponsor and its first Democrat backer – Texas representative Eddie Bernice Johnson. More news in brief.

The proposed Cosmetic Modernization Amendments of 2015 (H.R. 4075) now enjoys bipartisan support, with Rep. Eddie Bernice Johnson, D-Texas, signing on as a cosponsor March 14. The bill has been slower to pick up congressional backers than initially anticipated by the Independent Cosmetic Manufacturers and Distributors ([A#02151130006]). The trade group has been championing the bill as an alternative to the Personal Care Products Safety Act in the Senate, S. 1014, which it views as an overly burdensome threat to small business that lacks adequate preemption provisions to ensure national uniformity of regulations. Compared with the draft PCPSA's limited preemption framework, the CMA would bar states and local governments from establishing new requirements related to cosmetic ingredient use, labeling, registration and reporting, while seeking to void any existing programs of the sort ([A#02151130001]). The Personal Care Products Council, which has joined with prominent NGOs and leading industry players in support of the PCPSA, speculated recently that the best chance for updating cosmetics regulations in the US may be a compromise of the two bills in the next Congress Also see "PCPC: Cosmetic Legislation A Long Shot In 2016, But Objectives Are Clear" - HBW Insight, 2 March, 2016..

Sen. Kirsten Gillibrand, D-N.Y., signed on as a cosponsor of the Personal Care Products Safety Act March 7. Gillibrand was...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

FTC Consumer Privacy Policy Driven By ‘Straw Man’ Arguments – Commissioner Holyoak

 
• By Eileen Francis

The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.

FTC’s New Commissioner ‘Dismayed’ By Agency Overreach

 
• By Eileen Francis

FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements. 

Beauty Brands Not On TikTok Shop ‘Really Missing Out’ – KO-Pack

 
• By Eileen Francis

At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

More from HBW Insight

Lauder Says Tariffs Will Shave $100M from FY2026 Profits, As ‘Beauty Reimagined’ Lifts Topline

 
• By Eileen Francis

Estee Lauder says tariffs will hit its bottom line by $100m in fiscal year 2026, as it continues to work toward mitigation strategies. For the full fiscal year 2026, ELC estimates its sales will be in line with or ahead of prestige beauty in key markets, with reported sales in the range of 2%-5%.

Advocate For 7-OH Sees No ‘Public Health Emergency’ Or ‘Sort Of Signal’ For Scheduling

 
• By Malcolm Spicer

Holistic Alternative Recovery Trust says FDA should review data and other information available about the safety of all kratom extracts before it moves ahead on its proposal to recommend Schedule I controlled substance for 7-OH.

Kratom Industry Argues FDA Scheduling Plan Shows 7-OH At Root Of Botanical’s Regulatory Rot

 
• By Malcolm Spicer

Supporters of planned FDA action to recommend DEA schedule 7-OH include Global Kratom Coalition and Regulatory Service International consultancy firm. AHPA also supports FDA decision but says marketers of kratom extract mitragynine likely aren’t out of the weeds as far as questions about safety.